Business Models

The Innovation Gap in Executive Compensation

November 30, 2016

How the need for biopharma innovation extends to questions around executive compensation. By Carl Sjostrom and Ian Wilcox

Pharmaceutical Executive

The Rise of the CFO Strategist: Balancing Numbers and Know-how

October 24, 2016

Today’s C-suite executives in the life sciences must be experts in many disciplines. Pharm Exec examines the evolving role of the chief financial officer as not just a numbers and bottom-line risk manager but an integral contributor to overall corporate strategy and close partner to the CEO.

Pharmaceutical Executive

Pharm Exec's 15th Annual Industry Audit

August 31, 2016

As market headwinds persist, our latest industry review of shareholder value reveals a sharp performance differential between companies that pursue a strategy of specialized therapeutic focus and those that continue to rely on line diversity, size and scale.

Pharmaceutical Executive

Dealmaking in 2016: It’s Complicated

August 25, 2016

Pharm Exec convenes some of the industry’s top business development professionals and negotiators to talk about the current climate for biophamara dealmaking and the critical job of appraising new assets and their potential as market-worthy and transformative products for patients.

Registries and the Future of Medicine

May 16, 2016

Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.

Pharmaceutical Executive

Pharm Exec at the Vantage Point

May 04, 2016

The Boston biotech cluster proved an ideal setting for Pharm Exec's recent annual Editorial Advisory Board meeting, with the prevailing message that even the best environments for innovation require constant nurturing.

Who Will Win the Race to Treat NASH?

April 26, 2016

The liver disease non-alcoholic steatohepatitis (NASH) has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. The race is now to develop the first effective pharmacotherapy to treat it.